Aster Capital Management’s AbbVie ABBV Stock Holding History

Aster Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$697K	Sell	3,329 -7	-0.2%	-$1.55K	0.23%	104
2025 Q4	$762K	Sell	3,336 -5,579	-63%	-$1.27M	0.33%	50
2025 Q3	$2.06M	Buy	+8,915	New	+$1.82M	1.04%	13
2024 Q4	–	Sell	-7,406	Closed	-$1.46M	–	1078
2024 Q3	$1.46M	Buy	+7,406	New	+$1.38M	0.32%	78

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aster Capital Management's ABBV Position: Q1 2026 in Review

Aster Capital Management reduced its AbbVie (ABBV) stake by 0.21% in Q1 2026, selling an estimated $1.55K and leaving 3,329 shares worth $697K. The position accounts for 0.23% of the portfolio, ranked #104.

Aster Capital Management first reported a position in ABBV in Q3 2024 and has held it in 4 quarters since. The position peaked at $2.06M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Aster Capital Management held 3,329 shares of AbbVie worth $697K as of Q1 2026.
Aster Capital Management sold 7 AbbVie shares in Q1 2026, an estimated $1.55K.
AbbVie made up 0.23% of Aster Capital Management's portfolio in Q1 2026, its #104 holding.
Aster Capital Management first reported a position in AbbVie in Q3 2024 and has held it in 4 quarters since.
Aster Capital Management's AbbVie position peaked at $2.06M in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.